← Leaderboards
Wei Qiao Qiu
Tufts Medical Center
$11,176,716
Attributed
$18,279,502
Total exposure
11
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2005–24$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$18,279,502 · 11
By mechanism
R01$10,649,162 · 3
RF1$2,404,559 · 1
U19$2,290,949 · 2
K24$849,825 · 1
R56$810,558 · 1
K23$658,052 · 1
Top collaborators
- Rhoda Au8 shared
- Martin Rhys Farlow5 shared
- Neil W. Kowall5 shared
- Andrew Emili1 shared
- Thor Stein1 shared
- Haihao Zhu1 shared
Most similar at Tufts Medical Center
Same institution · by research overlap
- Wei Li$15,618,115
- Alysse Gail Wurcel$2,918,638
- Cheleste M Thorpe$2,799,755
- Ernst John Schaefer$8,539,085
- Vandana Menon$1,033,238
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseBrainCognitionMemoryBloodMild Cognitive ImpairmentPathologyAmyloidPlasmaImpaired CognitionBaseStructureSamplingS Disease RiskDiabetes MellitusMouse ModelIslet Amyloid PolypeptidePharmaceutical PreparationsPeptidesSafetyAnalogBlood - Brain Barrier AnatomyCognitive Function
Grant awards (38)
Characterizing the interaction of genetic vulnerabilities and chronic peripheral inflammation for AD risk$498,933
U19 · FY2024 · AG · contact PI
Identification and characterization of the CD31-ApoE-mCRP pathway for Alzheimer's disease in humans.$2,404,559
RF1 · FY2023 · AG · contact PI
Characterizing the interaction of genetic vulnerabilities and chronic peripheral inflammation for AD risk$498,934
U19 · FY2023 · AG · contact PI
Multi-center development of a novel diagnostic test for Alzheimer's disease$1,266,625
R01 · FY2022 · AG · contact PI
Characterizing the interaction of genetic vulnerabilities and chronic peripheral inflammation for AD risk$506,359
U19 · FY2022 · AG · contact PI
Multi-center development of a novel diagnostic test for Alzheimer's disease$1,275,411
R01 · FY2021 · AG · contact PI
Characterizing the interaction of genetic vulnerabilities and chronic peripheral inflammation for AD risk$385,936
U19 · FY2021 · AG · contact PI
Multi-center development of a novel diagnostic test for Alzheimer's disease$1,275,411
R01 · FY2020 · AG · contact PI
Characterizing the interaction of genetic vulnerabilities and chronic peripheral inflammation for AD risk$400,787
U19 · FY2020 · AG · contact PI
Multi-center development of a novel diagnostic test for Alzheimer's disease$1,275,411
R01 · FY2019 · AG · contact PI
Plasma Amylin Impact on Cognitive Function and Brain Morphology in the Framingham Heart Study$335,585
R01 · FY2019 · AG · contact PI
Midcareer Investigator Award in Amylin, Cognition, and Alzheimer's Disease$169,408
K24 · FY2019 · AG · contact PI
Multi-center development of a novel diagnostic test for Alzheimer's disease$1,306,078
R01 · FY2018 · AG · contact PI
Quantitative systems pharmacology and translational study of pramlintide for Alzheimer's disease$810,558
R56 · FY2018 · AG · contact PI
Plasma Amylin Impact on Cognitive Function and Brain Morphology in the Framingham Heart Study$335,585
R01 · FY2018 · AG · contact PI
Plasma Amylin Impact on Cognitive Function and Brain Morphology in the Framingham Heart Study$288,435
R01 · FY2018 · AG · contact PI
Midcareer Investigator Award in Amylin, Cognition, and Alzheimer's Disease$169,859
K24 · FY2018 · AG · contact PI
Plasma Amylin Impact on Cognitive Function and Brain Morphology in the Framingham Heart Study$335,585
R01 · FY2017 · AG · contact PI
Midcareer Investigator Award in Amylin, Cognition, and Alzheimer's Disease$170,298
K24 · FY2017 · AG · contact PI
Plasma Amylin Impact on Cognitive Function and Brain Morphology in the Framingham Heart Study$164,500
R01 · FY2017 · AG · contact PI
Plasma Amylin Impact on Cognitive Function and Brain Morphology in the Framingham Heart Study$335,585
R01 · FY2016 · AG · contact PI
Midcareer Investigator Award in Amylin, Cognition, and Alzheimer's Disease$170,723
K24 · FY2016 · AG · contact PI
Plasma Amylin Impact on Cognitive Function and Brain Morphology in the Framingham Heart Study$164,357
R01 · FY2016 · AG · contact PI
Plasma Amylin Impact on Cognitive Function and Brain Morphology in the Framingham Heart Study$335,585
R01 · FY2015 · AG · contact PI
Amylin as a Diagnostic Test and Potential Treatment for Alzheimers Disease$198,486
R21 · FY2015 · AG · contact PI
Midcareer Investigator Award in Amylin, Cognition, and Alzheimer's Disease$169,537
K24 · FY2015 · AG · contact PI
Amylin as a Diagnostic Test and Potential Treatment for Alzheimers Disease$245,550
R21 · FY2014 · AG · contact PI
Removal of Amyloid-beta Peptides from the Alzheimer's Brain$172,361
R41 · FY2014 · AG
Plasma Amyloid-beta Peptides, Depression and Alzheimer's Disease in the Homebound$328,728
R01 · FY2013 · AG · contact PI
Amyloid-beta Peptides, Depression and Alzheimer's Disease$400,461
R01 · FY2012 · AG · contact PI
Plasma Amyloid-beta Peptides, Depression and Alzheimer's Disease in the Homebound$401,529
R01 · FY2011 · AG · contact PI
Plasma Amyloid-beta Peptides, Depression and Alzheimer's Disease in the Homebound$406,696
R01 · FY2010 · AG · contact PI
Plasma Amyloid-beta Peptides, Depression and Alzheimer's Disease in the Homebound$417,595
R01 · FY2009 · AG · contact PI
Insulin, Cognitive Impairment and Alzheimer's Disease$133,827
K23 · FY2007 · AG · contact PI
Insulin, Cognitive Impairment and Alzheimer's Disease$133,784
K23 · FY2006 · AG · contact PI
Insulin, Cognitive Impairment and Alzheimer's Disease$133,167
K23 · FY2005 · AG
Insulin, Cognitive Impairment and Alzheimer's Disease$128,590
K23 · FY2004 · AG
Insulin, Cognitive Impairment and Alzheimer's Disease$128,684
K23 · FY2003 · AG